DiaMedica Therapeutics (DMAC) Capital Expenditures (2018 - 2026)
DiaMedica Therapeutics (DMAC) recorded Capital Expenditures of $3,000 in Q2 2026, down 50.0% from $6,000 a year earlier and down 62.5% from the prior quarter.
DiaMedica Therapeutics (DMAC) Capital Expenditures (2018 - 2026) Analysis & Trends
On a TTM basis, DiaMedica Therapeutics' Capital Expenditures came in at $33,000 as of Jun 30, 2026, down 2.9% year-over-year; for FY2025, it was $40,000, up 60.0% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of -3.2% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $25,000 in FY2024 (+4.2%), $24,000 in FY2023 (-70.4%), $81,000 in FY2022 (+268.2%) and $22,000 in FY2021 (-53.2%).
- Quarterly Capital Expenditures has ranged from $2,000 in Q3 2021 to $43,000 in Q3 2022 over the past five years.
- On a year-over-year basis, Capital Expenditures has declined for three consecutive quarters, with growth averaging 19.5% over the last seven quarters.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 357.1% in Q4 2022, against a decline of 90.6% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $8,000 (Q1 2026), $6,000 (Q4 2025) and $16,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | DiaMedica Therapeutics | 469.96 Mn | 259.92 Mn | - | 3,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Sep 30, 2022 | 43,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Mar 31, 2021 | 9,000.00 |
DiaMedica Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DMAC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();